Colestipol and clofibrate in hypercholesterolemia
- PMID: 4604239
- DOI: 10.1002/cpt1974162291
Colestipol and clofibrate in hypercholesterolemia
Similar articles
-
Controlled clinical trial of a new bile acid-sequestering resin, colestipol, in the treatment of hypercholesterolaemia.Med J Aust. 1973 Jun 23;1(25):1223-7. Med J Aust. 1973. PMID: 4579666 Clinical Trial. No abstract available.
-
Changes in plasma lipoprotein lipids in hypercholesterolaemic patients treated with the bile acid-sequestering resin, colestipol.Clin Sci Mol Med. 1974 Dec;47(6):547-57. doi: 10.1042/cs0470547. Clin Sci Mol Med. 1974. PMID: 4375013 No abstract available.
-
Response of hyperlipoproteinemia to colestipol.N Y State J Med. 1973 May 1;73(9):1068-70. N Y State J Med. 1973. PMID: 4512165 No abstract available.
-
[Basic principles of drug therapy of hyperlipoproteinemia].Orv Hetil. 1988 Nov 6;129(45):2391-9. Orv Hetil. 1988. PMID: 3054710 Review. Hungarian. No abstract available.
-
[The treatment of essential hyperlipidemia with clofibrate].Z Gesamte Inn Med. 1969 Jan 1;24(1):Suppl:184-7. Z Gesamte Inn Med. 1969. PMID: 4918619 Review. German. No abstract available.
Cited by
-
Electrocardiographic effects of probucol. A controlled prospective clinical trial.Eur J Clin Pharmacol. 1984;26(6):735-9. doi: 10.1007/BF00541934. Eur J Clin Pharmacol. 1984. PMID: 6386485 Clinical Trial.
-
Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia.Drugs. 1980 Mar;19(3):161-80. doi: 10.2165/00003495-198019030-00001. Drugs. 1980. PMID: 6988203 Review.